Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Heidegger

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
European Urology Oncology|June 26, 2025
Assessment of the Reporting and Incidence of Prostate Cancer Unconventional Histologies in Tertiary Referral Institutions: An Under-reported but Exploding Phenomenon?Giancarlo Marra, Geert J L H van Leenders, Guglielmo David, et al.
European Urology|June 24, 2023
European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy-A Multicenter StudyFelix Preisser, Raisa S Abrams-Pompe, Piter Jan Stelwagen, et al.
Prostate Cancer and Prostatic Diseases|October 26, 2022
Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysisPawel Rajwa, Takafumi Yanagisawa, Isabel Heidegger, et al.
European Urology Open Science|January 16, 2026
Impact of Negative Prostate-specific Membrane Antigen Positron Emission Tomography on the Decision to Perform a Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- to High-risk Prostate Cancer Patients: Results of an International SurveyFabio Zattoni, Pawel Rajwa, Veeru Kasivisvanathan, et al.
Cancer Medicine|August 10, 2021
A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancerIgor Tsaur, Isabel Heidegger, Jasmin Bektic, et al.
European Urology Focus|February 6, 2023
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional StudyFabio Zattoni, Giancarlo Marra, Alberto Martini, et al.
European Urology Oncology|August 21, 2023
Real-world Outcomes and Predictive Biomarkers for <sup>177</sup>Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational StudyMona Kafka, Andreas Horninger, Gianpaolo di Santo, et al.
The Journal of Urology|September 22, 2021
An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate CancerAlberto Martini, Timo F W Soeterik, Hester Haverdings, et al.
Clinical Genitourinary Cancer|January 24, 2024
Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter StudyMona Kafka, Giulia Giannini, Nastasiia Artamonova, et al.
European Urology Oncology|December 6, 2025
Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional StudyLorenzo Bianchi, Matteo Droghetti, Calogero Catanzaro, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
European Urology Oncology|June 26, 2025
Assessment of the Reporting and Incidence of Prostate Cancer Unconventional Histologies in Tertiary Referral Institutions: An Under-reported but Exploding Phenomenon?Giancarlo Marra, Geert J L H van Leenders, Guglielmo David, et al.
European Urology|June 24, 2023
European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy-A Multicenter StudyFelix Preisser, Raisa S Abrams-Pompe, Piter Jan Stelwagen, et al.
Prostate Cancer and Prostatic Diseases|October 26, 2022
Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysisPawel Rajwa, Takafumi Yanagisawa, Isabel Heidegger, et al.
European Urology Open Science|January 16, 2026
Impact of Negative Prostate-specific Membrane Antigen Positron Emission Tomography on the Decision to Perform a Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- to High-risk Prostate Cancer Patients: Results of an International SurveyFabio Zattoni, Pawel Rajwa, Veeru Kasivisvanathan, et al.
Cancer Medicine|August 10, 2021
A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancerIgor Tsaur, Isabel Heidegger, Jasmin Bektic, et al.
European Urology Focus|February 6, 2023
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional StudyFabio Zattoni, Giancarlo Marra, Alberto Martini, et al.
European Urology Oncology|August 21, 2023
Real-world Outcomes and Predictive Biomarkers for <sup>177</sup>Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational StudyMona Kafka, Andreas Horninger, Gianpaolo di Santo, et al.
The Journal of Urology|September 22, 2021
An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate CancerAlberto Martini, Timo F W Soeterik, Hester Haverdings, et al.
Clinical Genitourinary Cancer|January 24, 2024
Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter StudyMona Kafka, Giulia Giannini, Nastasiia Artamonova, et al.
European Urology Oncology|December 6, 2025
Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional StudyLorenzo Bianchi, Matteo Droghetti, Calogero Catanzaro, et al.
Pageof 16